High Level of Approval Observed for Polygenic Embryo Screening
By Elana Gotkine HealthDay Reporter
FRIDAY, May 17, 2024 -- There is a high level of approval for use of polygenic embryo screening, according to a study published online May 14 in JAMA Network Open.
Rémy A. Furrer, Ph.D., from the Center for Bioethics at Harvard Medical School in Boston, and colleagues surveyed U.S. adults to examine general attitudes, interests, and concerns relating to use of PES in a survey study. Data were collected from one stratified sample and one nonprobability sample. Sample 1 included 1,427 respondents with demographic data available; and sample 2 included 192 respondents.
The researchers found that 72.0 percent of sample 1 respondents expressed approval for PES and 81.9 percent expressed some interest in using PES if undergoing in vitro fertilization. Among these respondents, approval for using PES for embryo selection was notably high for physical and psychiatric health conditions (77.7 and 72.0 percent, respectively). However, minority approval was seen for embryo selection based on PES for behavioral traits and physical traits (36.0 and 30.3 percent, respectively). Pronounced concerns were seen for PES leading to false expectations and promoting eugenic practices; 55.3 and 54.8 percent of respondents found them very and extremely concerning, respectively. Sample 2 respondents were presented concerns at survey onset and survey end (95 versus 97), with concerns at survey end associated with less approval, more uncertainty, and slightly higher disapproval.
"The high level of public approval and interest regarding PES raises concerns over the lack of regulation and professional guidance on what type of polygenic embryo health conditions or traits should be screened and under what circumstances," the authors write.
One author received personal fees from MyHeritage.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
ASCO: Germline Variation Does Not Predict Taxane-Induced Peripheral Neuropathy
FRIDAY, June 7, 2024 -- Germline variation does not predict the risk of taxane-induced peripheral neuropathy (TIPN) in Black women receiving paclitaxel (once weekly) or docetaxel...
Several Drugs Linked to Risk for Aneurysmal Subarachnoid Hemorrhage
THURSDAY, June 6, 2024 -- Several commonly prescribed drugs are associated with aneurysmal subarachnoid hemorrhage (aSAH), according to a study published online June 5 in...
Social Determinants of Health Linked to TBI Incidence in Older Adults
THURSDAY, June 6, 2024 -- Social determinants of health are associated with traumatic brain injury (TBI) incidence among older adults, according to a study published online May 31...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.